BREAKING NEWS!: FDA Approves Apalutamide (Erleada) for the treatment of metastatic hormone-sensitive prostate cancer. Read More.
Go here to learn more or to get a mailed copy.
Home » Bio
PSMA-based Microfluidics-Capture of Circulating Prostate Cancer Cells:..
The Dan Fogelberg Creativity Award
Weill Cornell Medical College
FGFR Inhibition to Develop Effective Combination Therapies..
The University of Texas MD Anderson Cancer Center
Targeting Therapy-Induced Resistance Mechanisms in the Prostate..
Professor of Oncology, Adjunct Professor Genome Science and Pathology
Fred Hutchinson Cancer Research Center
University of Washington
Identification and integration of clinical features, genetic..
Paul Nguyen, MD:
Dana-Farber Cancer Institute, Harvard University
Anthony D’Amico, MD, PhD and Phillip Kantoff, MD
One of the causes for the initiation..
William G. Nelson, MD, PhD – :
Johns Hopkins Medicine
Induction of Synthetic Lethality with Epigenetic therapy (ISLET) for Systemic Treatment of Prostate Cancer
Srinivasan Yegnasubramanian, MD, PhD; Jun O. Liu, PhD; Stephen B. Baylin, MD; Michael A. Carducci, MD; Martin J. Aryee, PhD
When Dr. Peter Nelson is on the..
Banyan Biomarkers, Inc.